Elevance Health Inc

ELV

New York Stock Exchange. Currency in USD

502.89 +0.84 ( +0.17% )

Real time prices: December 19

Market Cap.
120.10B
Beta (5Y monthly)
0.90
Price/Earnings
17.93
EPS (TTM)
28.96
Forward Dividend
5.12 (0.98%)
Ex-Dividend Date
Dec 05, 2022
Volume
745,749
1y Target Est.
568.43
Day's Range
499.16
-
507.53
52 Week's Range
440.02
-
549.52

Historical Summary

Performance
EPS growth
Share Buybacks

About Elevance Health Inc

Sector
Healthcare
Industry
Healthcare Plans
Website
https://www.elevancehealth.com
Exchange
New York Stock Exchange (XNYS)
Shares Outstanding
241.08M
Employees
98200
Address
220 Virginia Avenue, Indianapolis, IN, United States, 46204
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Latest news

ELV vs. PGNY: Which Stock Is the Better Value Option?
ELV vs. PGNY: Which Stock Is the Better Value Option?

ELV vs. PGNY: Which Stock Is the Better Value Option?
By Zacks Investment Research - 6 weeks ago

Cigna (CI) Hits 52-Week High: What's Driving the Stock?
Cigna (CI) Hits 52-Week High: What's Driving the Stock?

Cigna's (CI) stock price is increasing on the back of solid performances in the Evernorth...
By Zacks Investment Research - 6 weeks ago

Is Elevance Health, Inc. (ELV) Stock Outpacing Its Medical Peers This Year?
Is Elevance Health, Inc. (ELV) Stock Outpacing Its Medical Peers This Year?

Here is how Elevance Health (ELV) and Genmab AS Sponsored ADR (GMAB) have performed compared...
By Zacks Investment Research - 7 weeks ago

Humana (HUM) Rises 23% in Past 6 Months: More Room to Run?
Humana (HUM) Rises 23% in Past 6 Months: More Room to Run?

Humana (HUM) is well-poised for growth on improving revenues, numerous contract wins and adequate cash-generating...
By Zacks Investment Research - 7 weeks ago

Acadia (ACHC) Reveals its Long-Term Goals: What You Should Know
Acadia (ACHC) Reveals its Long-Term Goals: What You Should Know

From 2022 to 2028, Acadia Healthcare (ACHC) expects to see a 9-11% CAGR in revenues.
By Zacks Investment Research - 7 weeks ago

The Joint (JYNT) Expands Operations to Alaska With 3 Clinics
The Joint (JYNT) Expands Operations to Alaska With 3 Clinics

The Joint's (JYNT) expansionary move is expected to be a prudent one, given the growing...
By Zacks Investment Research - 7 weeks ago

Cigna (CI) Focuses on Enhancing Pharmacy Offerings in 2023
Cigna (CI) Focuses on Enhancing Pharmacy Offerings in 2023

Cigna (CI) decides to integrate cost-effective biosimilars within its commercial formularies from next year in...
By Zacks Investment Research - 7 weeks ago

Centene (CNC) Concludes Magellan Rx Divestment to Prime
Centene (CNC) Concludes Magellan Rx Divestment to Prime

Centene (CNC) completes Magellan Rx divestment within the scheduled time.
By Zacks Investment Research - 7 weeks ago